The Normothermic Machine Perfusion (NMP) Market is experiencing significant momentum as transplant centres worldwide adopt warm-perfused organ preservation systems to improve graft viability and patient outcomes. These advanced systems maintain donor organs at near-physiological temperature, facilitating viability assessment, reducing ischemia-reperfusion injury, and expanding the pool of transplantable organs. Growing incidence of organ failure, shortage of donor organs and rising investment in transplant technologies are fueling this growth.
The Global Normothermic Machine Perfusion Market is projected to grow significantly from 1.63 USD Billion in 2024 to 10.13 USD Billion by 2035.The market is expected to experience a compound annual growth rate (CAGR) of 18.07% from 2025 to 2035.
As healthcare providers focus on improving transplant success rates and utilising marginal donor organs, NMP systems and services increasingly become integral to modern organ‐preservation workflows. Hospitals and specialty clinics are investing in robust perfusion platforms, consumables, and integrated service models to support transplantation of liver, kidney, lung and heart grafts. Emerging markets are also catching up, adding further scale to the opportunity.
🔥 Unlock your FREE Sample Report and get ahead with detailed insights and forecasts:
https://www.marketresearchfuture.com/sample_request/40190
Key Market Drivers
- Growing demand for donor organs and the need to improve utilisation rates of marginal or extended‐criteria donors is boosting adoption of NMP systems.
- Technological advances such as real‐time monitoring, AI-enhanced perfusion analytics and improved perfusate solutions are enhancing device efficacy and encouraging clinical uptake.
- Healthcare infrastructure expansion in emerging economies is enabling more transplant centres to deploy perfusion technology, driving regional growth.
- Rising regulatory support and reimbursement adjustments for advanced organ preservation technologies are helping reduce barriers to adoption.
- Clinical evidence showing improved graft‐function outcomes, shorter hospital stays, and lower complication rates with NMP is reinforcing adoption dynamics.
Market Segmentation & Regional Insights
The Global Normothermic Machine Perfusion Market is segmented based on Application, End User, Product Type, Technology, and Region. The Application segment includes liver, heart, kidney, and lung transplantation, with liver and kidney applications holding major shares due to the high demand for organ preservation. End Users comprise hospitals, transplant centers, and research organizations, where advanced perfusion systems are increasingly adopted to enhance organ viability. Product Type covers portable and standalone perfusion systems, catering to different clinical requirements. Technology segmentation includes pulsatile and non-pulsatile perfusion, both aimed at maintaining optimal organ functionality during preservation. Regionally, the market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with North America leading due to advanced transplant infrastructure and growing adoption of next-generation perfusion technologies.
The NMP Market can be segmented by Offering (Products such as systems and reagents/consumables, and Services), by Organ Type (Liver, Lung, Kidney, Heart, Others), by End User (Hospitals & ASCs, Specialty Clinics, Others) and by Region (North America, Europe, Asia-Pacific (APAC), Latin America, Middle East & Africa (MEA)).
💼 Purchase the full report for complete forecasts, competitive intelligence and region-specific breakdowns:
https://www.marketresearchfuture.com/checkout?step=2&report_id=40190¤cy=one_user-USD
Competitive Landscape
Key participants in the market include leading perfusion‐system manufacturers, transplant‐service providers and consumables suppliers. These organisations are focusing on advancing fluid‐management platforms, expanding transplant centre partnerships, and establishing global distribution networks. Strategic priorities include product innovation (miniaturised systems, portable units, multi‐organ capability), service expansion and enhanced clinical training/support programmes.
- SurgiCor
- InnovaHealth
- Prescient Surgical
- CVS Medical
- Tandem Diabetes
- Sentinel Heart
- Organ Recovery Systems
- Xvivo Perfusion
- Vestructa
- Fluent Medical
- TransMedics
- Vascular Insights
- LifePort
- Osmotica Pharmaceuticals
- DBA Medical
Growth Opportunities & Trends
- Expansion of multi-organ perfusion solutions enabling liver, lung, heart and kidney interventions within a single platform.
- Development of portable and transportation-friendly perfusion systems to enable donor-organ movement and remote transplantation workflows.
- Increasing adoption in emerging markets, especially Asia-Pacific, where transplant activity, donor‐pool awareness and infrastructure investment are rising rapidly.
- Integration of digital analytics and AI for perfusion monitoring, prognostics and predictive organ viability assessment—improving outcomes and operational efficiency.
- Growth in service-based models (e.g., perfusion-as-a-service) allowing hospitals to access NMP technology without heavy upfront capital build-out.
Browse In-depth Market Research Report (Pages, Charts, Tables, Figures) : https://www.marketresearchfuture.com/reports/normothermic-machine-perfusion-market-40190
Future Outlook
The NMP Market is poised for robust expansion over the next decade as transplant volumes rise, technology advances and access expands globally. Stakeholders who focus on scalable product design, service integration and emerging-market strategies will be best placed to capture value. The shift toward precision organ‐preservation workflows and broader adoption across organ types will continue to drive market evolution.
➤➤Explore MRFR’s Related Ongoing Coverage In Healthcare Domain:
Italy Healthcare Revenue Cycle Management Market
Spain Healthcare Revenue Cycle Management Market
US Healthcare Revenue Cycle Management Market
India Intravenous Solution Market
UK Intravenous Solution Market
US Intravenous Solution Market
